Evidence map›Paper›PMID 33753805›Full record

ArticleScientific reports2021

Crystal structure of RahU, an aegerolysin protein from the human pathogen Pseudomonas aeruginosa, and its interaction with membrane ceramide phosphorylethanolamine.

Eva Kočar, Tea Lenarčič, Vesna Hodnik, Anastasija Panevska, Yunjie Huang, Gregor Bajc, Rok Kostanjšek, Anjaparavanda P Naren, Peter Maček, Gregor Anderluh and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Eva Kočar *Department of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Tea Lenarčič *Department of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000, Ljubljana, Slovenia.
Vesna HodnikDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Anastasija PanevskaDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Yunjie HuangDepartment of Paediatrics, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Gregor BajcDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Rok KostanjšekDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Anjaparavanda P NarenDepartment of Paediatrics, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Peter MačekDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Gregor AnderluhDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000, Ljubljana, Slovenia.
Kristina SepčićDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia.
Marjetka PodobnikDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000, Ljubljana, Slovenia. marjetka.podobnik@ki.si.
Matej ButalaDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000, Ljubljana, Slovenia. matej.butala@bf.uni-lj.si.
University of Ljubljana · SINational Institute of Chemistry · SICincinnati Children's Hospital Medical Center · US

Funding

Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrheaR01DK080834 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Anjaparavanda P Naren · 2009 to 2026
$6.8M
NIDDK NIH HHS R01 DK080834
6 · The paper itself

Abstract

Aegerolysins are proteins produced by bacteria, fungi, plants and protozoa. The most studied fungal aegerolysins share a common property of interacting with membranes enriched with cholesterol in combination with either sphingomyelin or ceramide phosphorylethanolamine (CPE), major sphingolipids in the cell membranes of vertebrates and invertebrates, respectively. However, genome analyses show a particularly high frequency of aegerolysin genes in bacteria, including the pathogenic genera Pseudomonas and Vibrio; these are human pathogens of high clinical relevance and can thrive in a variety of other species. The knowledge on bacterial aegerolysin-lipid interactions is scarce. We show that Pseudomonas aeruginosa aegerolysin RahU interacts with CPE, but not with sphingomyelin-enriched artificial membranes, and that RahU interacts with the insect cell line producing CPE. We report crystal structures of RahU alone and in complex with tris(hydroxymethyl)aminomethane (Tris), which, like the phosphorylethanolamine head group of CPE, contains a primary amine. The RahU structures reveal that the two loops proximal to the amino terminus form a cavity that accommodates Tris, and that the flexibility of these two loops is important for this interaction. We show that Tris interferes with CPE-enriched membranes for binding to RahU, implying on the importance of the ligand cavity between the loops and its proximity in RahU membrane interaction. We further support this by studying the interaction of single amino acid substitution mutants of RahU with the CPE-enriched membranes. Our results thus represent a starting point for a better understanding of the role of P. aeruginosa RahU, and possibly other bacterial aegerolysins, in bacterial interactions with other organisms.

Indexed as

Models, MolecularProtein ConformationPseudomonas aeruginosaAnimalsBacterial ProteinsEthanolaminesFungal ProteinsHemolysin ProteinsHumansMembrane LipidsSf9 CellsStructure-Activity RelationshipaegerolysinBacterial ProteinsEthanolaminesFungal ProteinsHemolysin ProteinsMembrane Lipidsphosphorylethanolamine

Identifiers

PMID33753805
PMCPMC7985367
OpenAlexW3138818959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.